The Use of a Fully Automated Pulsating Support System (CuroCell® A4 CX20) in Pressure Ulcer Prevention and Treatment
- Conditions
- Pressure Ulcer, ButtockPressure UlcerPressure InjuryPressure Sore
- Interventions
- Device: 18 residents at least one PU category III-IV in the sacral areaDevice: 22 residentsat risk for PU development
- Registration Number
- NCT04890678
- Lead Sponsor
- University Ghent
- Brief Summary
Pressure Ulcers are a serious and common problem for residents admitted to long-term care facilities and community care patients. They represent a major burden to patients, carers and the Healthcare system, affecting approximately 1 in 20 community patients. International guidelines recommend the use of pressure redistribution support surfaces, systematic patient repositioning and preventive skin care to prevent pressure ulcers.
It has been acknowledged that a significant proportion of pressure ulcers are avoidable. The prevalence of pressure ulcers is 1 of the 4 common harms recorded in the UK NHS Safety Thermometer, a local improvement tool for measuring, monitoring and analyzing patient harms across a range of settings, including nursing homes, community nursing and hospitals on a monthly basis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- At risk of pressure ulcer development based on a Braden score ≤ 17 or pressure ulcer category III or IV
- Bedbound or chair bound
- Aged ≥ 65
- Short-stay residents (expected length of stay ≤14 days)
- End of life care
- Medical contraindication for patient repositioning/turning
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 18 residents at least one PU category III-IV in the sacral area 18 residents at least one PU category III-IV in the sacral area 18 residents at least one PU category III-IV in the sacral area aged 65 years or over 22 residentsat risk for PU development 22 residentsat risk for PU development 22 residents at risk for PU development, defined by a Braden score \< 12 and/or a Braden subscale 'Mobility' score ≤ 2 and/or the presence of non-blanchable erythema in the sacral area. aged 65 years or over
- Primary Outcome Measures
Name Time Method Pressure ulcer incidence 30 days Development of at least 1 Pressure ulcer category II+ during study period using European Pressure Ulcer Advisory Panel (EPUAP) classification system
Pressure ulcer healing 30 days Healing of pressure ulcers category III and IV during the 30-day study period - using the Pressure Ulcer Scale for Healing Tool (PUSH)
- Secondary Outcome Measures
Name Time Method Comfort 30 days perceived comfort and experiences of users of the mattress - using self-developed questionnaire
Trial Locations
- Locations (1)
WZC Hof ter Waarbeek
🇧🇪Asse, Vlaams-Brabant, Belgium